Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04925570 · ClinicalTrials.gov registry record · Phase 2
The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use
A Phase 2 study, sponsored by Woebot Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 258
- Enrollment target
NCT04925570: Completed Phase 2 study, sponsored by Woebot Health.
NCT04925570 is a Phase 2 study that has completed, run by Woebot Health. The registered enrollment target is 258 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04925570, a Phase 2 study, has completed, sponsored by Woebot Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 258 participants
- Enrollment target
Study Summary
This study aims to validate W-SUDs as a digitally-delivered substance use disorder program through a fully-powered randomized control trial that will test the comparative efficacy of the mobile-app based substance use disorder program (W-SUDs) to reduce substance use relative to a psychoeducation control condition, which has no cognitive behavioral therapy and the content is not delivered through a conversational user interface.
Primary Outcome
Change in number of substance use occasions in the past 30 days
Interventions
- DEVICE W-SUDs
- OTHER Digitally-delivered Psychoeducation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2022-11-14 |
| Est. Completion | 2023-08-17 |
| Phase | Phase 2 |
What the finished NCT04925570 record still lists
NCT04925570 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% higher).
The record links to 0 conditions, and to 2 interventions - of which W-SUDs is the first listed.
NCT04925570 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04925570 about?
NCT04925570 is a clinical study titled "The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use". This study aims to validate W-SUDs as a digitally-delivered substance use disorder program through a fully-powered randomized control trial that will test the comparative efficacy of the mobile-app based substance use disorder program (W-SUDs) to reduce substance use relative to a psychoeducation co...
What is the current status of trial NCT04925570?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 258 participants. The study started on 2022-11-14. Estimated completion is 2023-08-17.
What interventions are being tested in trial NCT04925570?
The interventions under investigation include: W-SUDs (DEVICE), Digitally-delivered Psychoeducation (OTHER).
Who is sponsoring clinical trial NCT04925570?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04925570's enrollment target sits among peer trials
258 212th of 2000 higher than 1,787 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI